NASDAQ · Analyst Forecast

Avalyn Pharma Inc. (AVLN) Stock Forecast & Price Target

$27.92 NASDAQ: AVLN Market Cap $1.24B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Avalyn Pharma Inc. (AVLN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Avalyn Pharma Inc., the average estimate for 2030 earnings per share is −$4.06; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$27.92
Consensus targetThe average of the price targets analysts have published.$60.00
Median targetThe middle target, less affected by a single outlier.$57.00
Highest targetThe most optimistic published target.$80.00
Lowest targetThe most pessimistic published target.$51.00
Difference from priceHow far the consensus target sits from today’s price.+114.9%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$0$0$01
2026$0$0$02
2027$0$0$02
2028$0$0$04
2029$0$0$01
2030$0$0$01

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$4.56−$4.56−$4.561
2026−$3.22−$3.20−$3.192
2027−$3.65−$3.09−$2.532
2028−$3.99−$3.16−$2.454
2029−$3.43−$3.43−$3.431
2030−$4.06−$4.06−$4.061

Avalyn Pharma Inc. (AVLN) forecast — frequently asked questions

What is the analyst price target for Avalyn Pharma Inc.?

Analysts covering Avalyn Pharma Inc. (AVLN) have a consensus price target of $60.00, 114.9% above the current price of $27.92. Published targets range from $51.00 to $80.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Avalyn Pharma Inc.'s earnings?

The average analyst estimate for Avalyn Pharma Inc. (AVLN) earnings per share in 2030 is -4.06, with individual estimates between -4.06 and -4.06.

How much revenue is Avalyn Pharma Inc. expected to make?

Analysts forecast Avalyn Pharma Inc. (AVLN) revenue of $0 in 2030, based on 1 published estimates.

How many analysts cover AVLN?

4 analysts contribute estimates for Avalyn Pharma Inc. (AVLN). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.